Cargando…
Adenosin A (2A) Rezeptorantagonisten als Therapieoption beim idiopathischen Parkinson-Syndrom?
In Parkinson’s disease, the focus has long been on motor symptoms and therapy with dopaminergic substances. In recent years, the importance of non-motor symptoms has been increasingly recognized, as they occur early in the course of the disease and restrict considerably the quality of life. However,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag
2022
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718593/ https://www.ncbi.nlm.nih.gov/pubmed/35226930 http://dx.doi.org/10.1055/a-1771-6225 |